ES485153A1 - Procedimiento para la obtencion de 6-arilpiridazin-3-onas - Google Patents

Procedimiento para la obtencion de 6-arilpiridazin-3-onas

Info

Publication number
ES485153A1
ES485153A1 ES485153A ES485153A ES485153A1 ES 485153 A1 ES485153 A1 ES 485153A1 ES 485153 A ES485153 A ES 485153A ES 485153 A ES485153 A ES 485153A ES 485153 A1 ES485153 A1 ES 485153A1
Authority
ES
Spain
Prior art keywords
arylpyridazine
ones
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485153A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES485153A1 publication Critical patent/ES485153A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Procedimiento para la obtención de 6-arilpiridazin-3-onas de fórmula general I **(Fórmula)** donde R1 significa un resto 4-bifenililo ó 4- fenoxifenilo insustituido, o sustituido en la posición 4'' por F, C1, Br o I, R2 significa H, alquilo o hidroxialquilo, en cada caso con 1-4 átomos de carbono o piridilo, R3 y R6, en cada caso, significan H, alquilo con 1-4 átomos de caborno, o juntos -(CH2)4- y R4 y R5 en cada caso significan H o juntos un enlace C-C, donde, sin embargo, como mínimo uno de los restos R2, R3 y R6 es distintivo a hidrógeno.
ES485153A 1978-10-19 1979-10-18 Procedimiento para la obtencion de 6-arilpiridazin-3-onas Expired ES485153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782845456 DE2845456A1 (de) 1978-10-19 1978-10-19 6-arylpyridazin-3-one und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES485153A1 true ES485153A1 (es) 1980-05-16

Family

ID=6052528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES485153A Expired ES485153A1 (es) 1978-10-19 1979-10-18 Procedimiento para la obtencion de 6-arilpiridazin-3-onas

Country Status (12)

Country Link
US (1) US4289774A (es)
EP (1) EP0010156B1 (es)
JP (1) JPS5557570A (es)
AT (1) ATE1624T1 (es)
AU (1) AU532749B2 (es)
CA (1) CA1134826A (es)
DE (2) DE2845456A1 (es)
ES (1) ES485153A1 (es)
HU (1) HU180264B (es)
IL (1) IL58473A (es)
YU (1) YU252479A (es)
ZA (1) ZA795561B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3124699A1 (de) * 1981-06-24 1983-01-13 Basf Ag, 6700 Ludwigshafen Neue 2-aryl-3,4-diaza-bicyclo(4.n.0.)alken-(2)-one-(5),verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3321012A1 (de) * 1983-06-10 1984-12-13 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
US4631279A (en) * 1984-10-15 1986-12-23 Eli Lilly And Company 6-(pyridinylphenyl)dihydropyridazinones as inotropic agents
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
US4806535A (en) * 1987-07-22 1989-02-21 Rorer Pharmaceutical Corporation Imidazolylphenyl and 1,2,4-triazolylphenyl benzopyridazinone and pyridopyridazinone compounds and their use for increasing cardiatonic contractility
GB8824458D0 (en) * 1988-10-19 1988-11-23 Orion Yhtymae Oy Substituted pyridazinones
DE19514568A1 (de) 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
ATE233247T1 (de) * 1997-01-15 2003-03-15 Altana Pharma Ag Phtalazinonen
US7074959B2 (en) * 2002-08-01 2006-07-11 New Mexico Highlands University Methods and systems for remediating hydrazine-contaminated equipment and/or surfaces
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
BR112014031068A2 (pt) 2012-06-12 2017-06-27 Abbvie Inc derivados piridinona e piridazinona
DK3442972T3 (da) 2016-04-15 2020-04-27 Abbvie Inc Bromdomænehæmmere

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670683A1 (de) * 1966-03-31 1970-01-02 Bayer Ag Verfahren zur Herstellung neuartiger Arylaether
FR1604863A (es) * 1967-11-22 1972-04-17
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
US3689652A (en) * 1970-10-09 1972-09-05 William Vincent Curran Method of lowering blood pressure in mammals
US4088762A (en) * 1971-02-22 1978-05-09 Bdh Pharmaceuticals Limited 6-(P-PIPERAZINO)-PHENYL-4,5-DIHYDRO-3(2H)pyridazinones
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
US3812256A (en) * 1971-06-08 1974-05-21 American Cyanamid Co Novel method for lowering blood pressure in mammals
US3840662A (en) * 1971-08-05 1974-10-08 Shimamoto Takio Method of treating atherosclerosis using 4-hydroxymethyl-1-keto-1,2-dihydrophthalazine or acid salts thereof
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
JPS6037101B2 (ja) * 1977-03-09 1985-08-24 三共株式会社 フエニルピリダジノン誘導体の製法

Also Published As

Publication number Publication date
DE2845456A1 (de) 1980-08-14
ZA795561B (en) 1980-09-24
IL58473A (en) 1985-07-31
CA1134826A (en) 1982-11-02
IL58473A0 (en) 1980-01-31
AU532749B2 (en) 1983-10-13
EP0010156A1 (de) 1980-04-30
DE2963814D1 (en) 1982-11-11
AU5193379A (en) 1980-04-24
ATE1624T1 (de) 1982-10-15
YU252479A (en) 1983-01-21
EP0010156B1 (de) 1982-10-06
JPS5557570A (en) 1980-04-28
US4289774A (en) 1981-09-15
HU180264B (en) 1983-02-28

Similar Documents

Publication Publication Date Title
ES8407025A1 (es) Un procedimiento para preparar derivados de nicotinamida.
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES485153A1 (es) Procedimiento para la obtencion de 6-arilpiridazin-3-onas
ZA846093B (en) Heptaose compounds,preparation and use thereof
ES445928A1 (es) Procedimiento para la preparacion de compuestos de imidazo- linio cuaternarios.
US4167625A (en) Trans-4,5,13,14-tetradehydro-PGI1 amides
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
IL73721A0 (en) Substituted o-acylglycosylamides,their preparation and pharmaceutical compositions containing them
ES467861A1 (es) Procedimiento de preparacion de espiro-oxazolidinas esteroi-des y sus esteroisomeros.
ES8401088A1 (es) Un procedimiento para la produccion de derivados de fosforamida.
IL74269A0 (en) 2-alkoxyaminosulfonylbenzene-sulfonylureas,their production and their use as herbicides
ES8304571A1 (es) "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas".
GR82272B (es)
EG17841A (en) New-benzotriazoles the preparation thereof and their use as fungicides
ES475345A1 (es) Un procedimiento para la preparacion de diclorovinilciclobu-tanonas
ES8302695A1 (es) Procedimiento para la obtencion de nuevos compuestos de poliglicidilurazol n.substituidos.
ES481057A1 (es) Procedimiento para preparar una composicion protectora de - plantas que comprende como antidoto un derivado de 1,4-oxa- za-spirohidrocarburo.
SE8004622L (sv) Acylaminobensoesyraderivat
GB1492380A (en) Substituted trithiolans and their use as flavouring agent
ES8505984A1 (es) Procedimiento de preparar 2,9-dihidrofuranos
US4198500A (en) Trans-4,5-didehydro-PGI1 amides
ES8504772A1 (es) Un procedimiento para preparar un compuesto de 7-(4-piridil)-1,8-naftiridina.
ES8304540A1 (es) Un procedimiento para producir una nueva carboxiamidoamina-sustituida.
ZA828642B (en) Tridigitoxosides, processes for their preparation and pharmaceutical composition thereof
IL75710A (en) N-alkylphenyl-alpha-substituted hexahydro-1h-pyrrolizine-7a-acetamides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000301